首页> 外文OA文献 >Plasma exosome‑encapsulated microRNA‑21 and microRNA‑92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer

【2h】

Plasma exosome‑encapsulated microRNA‑21 and microRNA‑92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer

机译：血浆外渗封装的MicroRNA-21和MicroRNA-92a是有前途的生物标志物，用于预测胃癌患者的腹膜复发

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Naruyoshi Soeda; Hisae Iinuma; Yusuke Suzuki; Daisuke Tsukahara; Hironori Midorikawa; Yuichi Igarashi; Yoshimasa Kumata; Masahiro Horikawa; Takashi Kiyokawa; Takeo Fukagawa; Ryoji Fukushima;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Exosome-encapsulated microRNA-23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage [J] . Kumata Yoshimasa, Iinuma Hisae, Suzuki Yusuke, Oncology reports . 2018,第1期

机译：外出封装的microRNA-23B作为微创液体生物标志物，用于预测每个肿瘤阶段胃癌患者的复发和预后
2. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients [J] . Kawamura Sachiyo, Iinuma Hisae, Wada Keita, Journal of hepato-biliary-pancreatic sciences . 2019,第2期

机译：外出封装的MicroRNA-4525，MicroRNA-451A和MicroRNA-21在门静脉血液中是一种高敏感的液体生物标志物，用于选择高风险的胰腺导管腺癌患者
3. Usefulness of exosome‐encapsulated microRNA‐451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma [J] . Takahasi Kunihiko, Iinuma Hisae, Wada Keita, Journal of hepato-biliary-pancreatic sciences . 2018,第2期

机译：封闭微小RORNA-451a作为微创生物标志物，用于预测胰腺导管腺癌中复发和预后的微创生物标志物
4. Promising Biomarkers: MicroRNAs at Diagnosis, Therapy and Prognostic Evaluation of Breast Cancer [C] . Dalin Lu, Nan Wang, Xinghua Liao, International conference on applied biotechnology . 2014

机译：有前途的生物标志物：MicroRNA在乳腺癌的诊断，治疗和预后评估中的作用
5. Using imputed microRNA regulation based on weighted ranked expression and putative microRNA targets and analysis of variance to select microRNAs for predicting prostate cancer recurrence. [D] . Wang, Qi. 2014

机译：使用基于加权排名表达和推定的microRNA靶标的估算microRNA调控以及方差分析来选择可预测前列腺癌复发的microRNA。
6. Plasma exosome-encapsulated microRNA-21 and microRNA-92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer [O] . Naruyoshi Soeda, Hisae Iinuma, Yusuke Suzuki, -1

机译：血浆囊泡包裹的microRNA-21和microRNA-92a是有前景的预测胃癌患者腹膜复发的生物标志物
7. Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage [O] . Yoshimasa Kumata, Hisae Iinuma, Yusuke Suzuki, 2018

机译：外肌包裹的microRNA-23B作为微创液体生物标志物，用于预测每种肿瘤阶段胃癌患者的复发和预后

Plasma exosome‑encapsulated microRNA‑21 and microRNA‑92a are promising biomarkers for the prediction of peritoneal recurrence in patients with gastric cancer

著录项

引文网络

相似文献

相关主题

期刊订阅